<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03453827</url>
  </required_header>
  <id_info>
    <org_study_id>PEX Study</org_study_id>
    <nct_id>NCT03453827</nct_id>
  </id_info>
  <brief_title>Long-term Intraocular Lens (IOL) Decentration and Tilt in Eyes With Pseudoexfoliation Syndrome (PES) Following Cataract Surgery</brief_title>
  <official_title>Assessment of Long-term Intraocular Lens (IOL) Decentration and Tilt in Eyes With Pseudoexfoliation Syndrome (PES) Following Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Hietzing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Hietzing</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate long-term intraocular lens (IOL) decentration and tilt in eyes with
      pseudoexfoliation syndrome (PES) following cataract surgery using Visante anterior segment
      OCT and iTrace Visual Function Analyzer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      64 eyes following cataract surgery from 2009 to 2012 were included, 34 eyes had PES, 30 eyes
      did not show PES. A standard phacoemulsification procedure followed by IOL implantation was
      performed and patients were followed 4-6 years after surgery (mean=69 months). Best corrected
      visual acuity (BCVA), intraocular pressure (IOP) and capsulorhexis size were measured. IOL
      tilt and IOL decentration were evaluated using Visante Omni anterior segment OCT (Carl Zeiss
      Jena GmBH, Germany). The iTrace VFA (Visual Function Analyzer, Topcon Medical Systems, Inc.)
      was used to measure internal, corneal and total optical aberrations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">April 28, 2017</completion_date>
  <primary_completion_date type="Actual">April 28, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IOL decentration</measure>
    <time_frame>4-6 years after cataract surgery</time_frame>
    <description>decentration of IOL is measured using Hoya iTrace</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IOL tilt</measure>
    <time_frame>4-6 years after cataract surgery</time_frame>
    <description>tilt of implanted IOL is measured using Hoya iTace</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IOL decentration</measure>
    <time_frame>4-6 years after cataract surgery</time_frame>
    <description>decentration of IOL is measured using Zeiss OCT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IOL tilt</measure>
    <time_frame>4-6 years after cataract surgery</time_frame>
    <description>tilt of implanted IOL is measured using Zeiss OCT</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">37</enrollment>
  <condition>Cataract</condition>
  <condition>Pseudoexfoliation Syndrome</condition>
  <condition>Pseudophakia</condition>
  <arm_group>
    <arm_group_label>PEX</arm_group_label>
    <description>Patients after Cataract surgery with PES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients after Cataract surgery without PES</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>PEX</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent standard procedure cataract surgery with or without
        Pseudoexfoliation Syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients 4-6 years after standard cataract surgery

          -  pseudoexfoliation Syndrome (PES)

        Exclusion Criteria:

          -  Diabetic retinopathy

          -  Age related macula Degeneration

          -  retinal bloodvessel disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>125 Years</maximum_age>
  </eligibility>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>February 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2018</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Hietzing</investigator_affiliation>
    <investigator_full_name>Kata Mihaltz</investigator_full_name>
    <investigator_title>Oberarzt M.D. PhD FEBO</investigator_title>
  </responsible_party>
  <keyword>Pseudoexfoliation Syndrome</keyword>
  <keyword>Cataract</keyword>
  <keyword>Aberration</keyword>
  <keyword>IOL decentration</keyword>
  <keyword>IOL tilt</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Exfoliation Syndrome</mesh_term>
    <mesh_term>Pseudophakia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

